Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
BETHESDA, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of ...
Hosted on MSN25m
Staggering Number Of Potentially Unsafe Elderly Drivers Still Behind Wheel, Study Warns
A new study reveals a staggering number of elderly Americans experiencing cognitive decline continue to drive, raising ...
It’s time to pay attention to the bird flu
Today we’re examining a concerning development in the spread of bird flu in the US. But first: Even though Peter Yarrow ...
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...